Stay updated on DBF Safety & Tolerability in Epilepsy Clinical Trial
Sign up to get notified when there's something new on the DBF Safety & Tolerability in Epilepsy Clinical Trial page.

Latest updates to the DBF Safety & Tolerability in Epilepsy Clinical Trial page
- Check3 days agoChange DetectedThe study record for the Phase 3 diazepam buccal film epilepsy trial is now displayed, including eligibility criteria, study design and outcomes, locations, and study documents.SummaryDifference49%

- Check10 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0; the study record is still inaccessible.SummaryDifference0.2%

- Check17 days agoChange DetectedA banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434, with updates and FAQs available.SummaryDifference1%

- Check24 days agoChange DetectedThe 403 error response is replaced by the standard ClinicalTrials.gov page shell and footer, while the study details are not displayed.SummaryDifference0.8%

- Check31 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0. The page still shows a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check52 days agoChange DetectedThe study record page now displays a 403 Forbidden error, replacing the usual study details with an access-denied message. This indicates that the record is not accessible at the moment.SummaryDifference18%

Stay in the know with updates to DBF Safety & Tolerability in Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DBF Safety & Tolerability in Epilepsy Clinical Trial page.